Search

You searched for "surgery"

2561 results found
Neuro-Ophthalmology journal cover image

Patterns of binocular diplopia in giant cell arteritis (GCA)

3 February 2023 | | EYE - Neuro-ophthalmology | Diplopia, giant cell arteritis, population-based
Giant cell arteritis (GCA) is a granulomatous vasculitis that targets medium and large sized vessels. Binocular diplopia has been reported in a small number of patients with visual manifestations of GCA. It can be caused by ischaemia in any segment...
Ophthalmologica journal cover image.

Type 3 macular neovascularisation (MNV) due to age-related macular degeneration

3 October 2024 | | EYE - Vitreo-Retinal
This paper systematically reviews and summarises the current knowledge on type 3 neovascularisation due to age-related macular degeneration which is defined as neovascularisation originating from the retinal deep capillary plexus that grows towards the outer retina often penetrating the level...

The 2021-2022 ophthalmology ST1 application process

3 October 2022 | | EYE - General
Harry Rosen updates us on what is involved in the current UK Ophthalmology Specialist Training (OST) programme application process. The process of applying to the UK Ophthalmology Specialist Training (OST) programme is constantly changing each year, adapting to the needs...

Visual disturbance heralding stroke: are we seeing the signs in time?

6 April 2021 | | EYE - Neuro-ophthalmology, EYE - General
Isolated visual symptoms may be an early presenting feature of stroke, and timely recognition of such atypical cases is important because treatment for stroke has a limited time-window of efficacy. Stroke occurs in approximately 150,000 people per year in the...

DR-NET National DR Workshop in Tanzania: Policy, training and technology

4 August 2025 | | EYE - Imaging, EYE - Vitreo-Retinal
Diabetic retinopathy (DR) is a leading cause of moderate to severe visual impairment (VI) and blindness worldwide, posing a significant public health challenge. As the prevalence of diabetes continues to rise globally, particularly in low- and middle-income countries (LMICs), the...

Study flags evidence gaps in AI eye imaging devices approved for patient care

16 June 2025 | AI, Oculomics, Imaging, UCL, NIHR
Uneven evidence and poor data transparency revealed in review of AI as a medical device. A review of regulator-approved medical AI models in eye care has found that they vary widely in providing evidence for clinical performance and lacked transparency...

Specialty doctor interviews

1 February 2019 | | EYE - General
I started my training as an ophthalmologist in the Wild West of Carmarthenshire where I did my first laser procedure, first phacoemulsification and first slit-lamp examination. All of these firsts were done under the tutelage of very skilled staff grade...

Internuclear ophthalmoplegia: a case study

3 June 2024 | | EYE - General
A 44-year-old patient presents with binocular, mostly horizontal diplopia when fixating on moving objects. This has been ongoing for approximately five years. He is known to have multiple sclerosis and had an episode of optic neuritis six years prior in...

The blue-light hazard – is it true?

1 February 2019 | | EYE - Vitreo-Retinal, EYE - General
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: The blue-light hazard – is it true? Blue light is part of the visible optical spectrum...

Management of DMO and PDR in 2019

10 October 2019 | | EYE - Vitreo-Retinal, EYE - General
An evidence-based approach to the management of diabetic macular oedema (DMO) and proliferative diabetic retinopathy (PDR) in 2019 was outlined by Sobha Sivaprasad, UK, in presentations during the Diabetic Retina scientific session September 6 2019, at the 19th European Society...

Digital eyecare – enabling better communication between primary and secondary care

3 June 2021 | | EYE - Imaging, EYE - General
Alexander Chiu and his co-authors highlight innovations influencing healthcare advancement and how trainees can get involved. Hospital eye services (HES) were under great pressure to meet demand, even before the COVID-19 pandemic. This pressure has increased with the cancellation and...

Aspiration of anteriorly migrated dexamethasone implant using an 18G intravenous cannula

4 December 2025 | | EYE - Cornea, EYE - Vitreo-Retinal
Intravitreal dexamethasone (Ozurdex 0.7mg) is a biodegradable, sustained-release implant used to manage diabetic macular oedema, macular oedema secondary to retinal vein occlusion, and non-infectious posterior uveitis due to its anti-inflammatory effects and VEGF suppression [1]. While effective, the implant may...